- GLP-1 therapy for obesity management requires multidisciplinary care and nutritional assessment.
- Gastrointestinal side effects, nutritional deficiencies, and musculoskeletal loss are major concerns.
- Health equity disparities affect access to GLP-1s for obesity treatment.
- Food is Medicine programs and comprehensive care plans are crucial for successful GLP-1 therapy.
- The U.S. list price range of GLP-1s for obesity treatment is $12,000 to $16,000 annually.
Source: Obesity Journal
